{"count": 30, "results": [{"_id": "35900801", "pmid": 35900801, "pmcid": "PMC9422254", "title": "Effects and safety of metformin in patients with concurrent diabetes mellitus and chronic obstructive pulmonary disease: a systematic review and meta-analysis", "journal": "Endocr Connect", "authors": ["Liang Z", "Yang M", "Xu C", "Zeng R", "Dong L"], "date": "2022-08-22T00:00:00Z", "doi": "10.1530/EC-22-0289", "meta_date_publication": "2022 Sep 1", "meta_volume": "11", "meta_issue": "9", "meta_pages": "", "score": 50278.09, "text_hl": "The following terms were used in the searches: ('@<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@Chronic Obstructive Lung Disease@@@' OR '@<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@Chronic Obstructive Pulmonary Disease@@@' OR 'COAD' OR '@<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@COPD@@@' OR '@<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@Chronic Obstructive Airway Disease@@@' OR '@<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@Chronic Obstructive Pulmonary Disease@@@' OR '@<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@Airflow Obstruction@@@, Chronic' OR '@<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@Airflow Obstructions@@@, Chronic' OR 'Chronic @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@Airflow Obstructions@@@' OR 'Chronic @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@Airflow Obstruction@@@' OR '@DISEASE_Lung_Diseases @DISEASE_MESH:D008171 @@@Pulmonary Disease@@@, @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@Chronic Obstructive@@@') AND ('@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Dimethylbiguanidine@@@' OR '@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Dimethylguanylguanidine@@@' OR '@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Glucophage@@@' OR '@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin Hydrochloride@@@' OR 'Hydrochloride, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@' OR '@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin HCl@@@' OR '@CHEMICAL_Hydrochloric_Acid @CHEMICAL_MESH:D006851 @@@HCl@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@' OR '@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@'). ", "citations": {"NLM": "Liang Z, Yang M, Xu C, Zeng R, Dong L. Effects and safety of metformin in patients with concurrent diabetes mellitus and chronic obstructive pulmonary disease: a systematic review and meta-analysis Endocr Connect. 2022 Sep 1;11(9):. PMID: 35900801", "BibTeX": "@article{35900801, title={Effects and safety of metformin in patients with concurrent diabetes mellitus and chronic obstructive pulmonary disease: a systematic review and meta-analysis}, author={Liang Z and Yang M and Xu C and Zeng R and Dong L}, journal={Endocr Connect}, volume={11}, number={9}}"}}, {"_id": "33267895", "pmid": 33267895, "pmcid": "PMC7709288", "title": "Use of antidiabetic medications and risk of chronic obstructive pulmonary disease exacerbation requiring hospitalization: a disease risk score-matched nested case-control study", "journal": "Respir Res", "authors": ["Wang MT", "Lai JH", "Huang YL", "Kuo FC", "Wang YH", "Tsai CL", "Tu MY"], "date": "2020-12-02T00:00:00Z", "doi": "10.1186/s12931-020-01547-1", "meta_date_publication": "2020 Dec 2", "meta_volume": "21", "meta_issue": "1", "meta_pages": "319", "score": 50268.605, "text_hl": "Figure 3 indicates that an unmeasured confounder needs to be 2 times less prevalent in @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ users then in non-@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ users and to increase the risk of severe @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@COPD@@@ exacerbation by more than three to sixfold to completely explain the observed association between current use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and risk of severe @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@COPD@@@ exacerbation.", "citations": {"NLM": "Wang MT, Lai JH, Huang YL, Kuo FC, Wang YH, Tsai CL, Tu MY. Use of antidiabetic medications and risk of chronic obstructive pulmonary disease exacerbation requiring hospitalization: a disease risk score-matched nested case-control study Respir Res. 2020 Dec 2;21(1):319. PMID: 33267895", "BibTeX": "@article{33267895, title={Use of antidiabetic medications and risk of chronic obstructive pulmonary disease exacerbation requiring hospitalization: a disease risk score-matched nested case-control study}, author={Wang MT and Lai JH and Huang YL and Kuo FC and Wang YH and Tsai CL and Tu MY}, journal={Respir Res}, volume={21}, number={1}, pages={319}}"}}, {"_id": "35082306", "pmid": 35082306, "pmcid": "PMC8792053", "title": "Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatment", "journal": "Sci Rep", "authors": ["Kahnert K", "Andreas S", "Kellerer C", "Lutter JI", "Lucke T", "Yildirim Ö", "Lehmann M", "Seissler J", "Behr J", "Frankenberger M", "Bals R", "Watz H", "Welte T", "Trudzinski FC", "Vogelmeier CF", "Alter P", "Jörres RA", "COSYCONET Study Group"], "date": "2022-01-26T00:00:00Z", "doi": "10.1038/s41598-022-05276-x", "meta_date_publication": "2022 Jan 26", "meta_volume": "12", "meta_issue": "1", "meta_pages": "1435", "score": 50266.69, "text_hl": "Reduced decline of lung diffusing capacity in @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@COPD@@@ @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment", "citations": {"NLM": "Kahnert K, Andreas S, Kellerer C, Lutter JI, Lucke T, Yildirim Ö, Lehmann M, Seissler J, Behr J, Frankenberger M, Bals R, Watz H, Welte T, Trudzinski FC, Vogelmeier CF, Alter P, Jörres RA, COSYCONET Study Group. Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatment Sci Rep. 2022 Jan 26;12(1):1435. PMID: 35082306", "BibTeX": "@article{35082306, title={Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatment}, author={Kahnert K and Andreas S and Kellerer C and Lutter JI and Lucke T and Yildirim Ö and Lehmann M and Seissler J and Behr J and Frankenberger M and Bals R and Watz H and Welte T and Trudzinski FC and Vogelmeier CF and Alter P and Jörres RA and COSYCONET Study Group}, journal={Sci Rep}, volume={12}, number={1}, pages={1435}}"}}, {"_id": "33407433", "pmid": 33407433, "pmcid": "PMC7789818", "title": "Outcomes associated with comorbid diabetes among patients with COPD exacerbation: findings from the ACURE registry", "journal": "Respir Res", "authors": ["Mao X", "Liang C", "Niu H", "Dong F", "Huang K", "Chen Y", "Huang K", "Zhan Q", "Zhang Y", "Huang Y", "Yang T", "Wang C"], "date": "2021-01-06T00:00:00Z", "doi": "10.1186/s12931-020-01607-6", "meta_date_publication": "2021 Jan 6", "meta_volume": "22", "meta_issue": "1", "meta_pages": "7", "score": 50266.207, "text_hl": "Another one was done by Habib et al., which found corticosteroids was not associated with a significant increase in Hemoglobin @VARIANT_tmVar:c|SUB|A|1|C;HGVS:c.1A>C;VariantGroup:0 @@@A1C@@@ (HbA1c) among @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@AECOPD@@@ @SPECIES_9606 @@@patients@@@. (2) @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ could be considered in the treatment for @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@COPD@@@ @SPECIES_9606 @@@patients@@@ since it may reduce death rate of these @SPECIES_9606 @@@patients@@@ due to its pleiotropic anti-@DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ and antioxidant effect. ", "citations": {"NLM": "Mao X, Liang C, Niu H, Dong F, Huang K, Chen Y, Huang K, Zhan Q, Zhang Y, Huang Y, Yang T, Wang C. Outcomes associated with comorbid diabetes among patients with COPD exacerbation: findings from the ACURE registry Respir Res. 2021 Jan 6;22(1):7. PMID: 33407433", "BibTeX": "@article{33407433, title={Outcomes associated with comorbid diabetes among patients with COPD exacerbation: findings from the ACURE registry}, author={Mao X and Liang C and Niu H and Dong F and Huang K and Chen Y and Huang K and Zhan Q and Zhang Y and Huang Y and Yang T and Wang C}, journal={Respir Res}, volume={22}, number={1}, pages={7}}"}}, {"_id": "33926423", "pmid": 33926423, "pmcid": "PMC8086317", "title": "Combination therapies with thiazolidinediones are associated with a lower risk of acute exacerbations in new-onset COPD patients with advanced diabetic mellitus: a cohort-based case-control study", "journal": "BMC Pulm Med", "authors": ["Chen KY", "Wu SM", "Tseng CH", "Lee KY", "Lin YH", "Liu HY", "Chien LN"], "date": "2021-04-29T00:00:00Z", "doi": "10.1186/s12890-021-01505-7", "meta_date_publication": "2021 Apr 29", "meta_volume": "21", "meta_issue": "1", "meta_pages": "141", "score": 50256.344, "text_hl": "Among new-onset @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@COPD@@@-@DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2DM@@@ @SPECIES_9606 @@@patients@@@, 65,370 were prescribed @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and 2nd-line OADs before the date of @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@COPD@@@ onset. ", "citations": {"NLM": "Chen KY, Wu SM, Tseng CH, Lee KY, Lin YH, Liu HY, Chien LN. Combination therapies with thiazolidinediones are associated with a lower risk of acute exacerbations in new-onset COPD patients with advanced diabetic mellitus: a cohort-based case-control study BMC Pulm Med. 2021 Apr 29;21(1):141. PMID: 33926423", "BibTeX": "@article{33926423, title={Combination therapies with thiazolidinediones are associated with a lower risk of acute exacerbations in new-onset COPD patients with advanced diabetic mellitus: a cohort-based case-control study}, author={Chen KY and Wu SM and Tseng CH and Lee KY and Lin YH and Liu HY and Chien LN}, journal={BMC Pulm Med}, volume={21}, number={1}, pages={141}}"}}, {"_id": "36071848", "pmid": 36071848, "pmcid": "PMC9441545", "title": "Cardiovascular outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease", "journal": "Front Pharmacol", "authors": ["Yen FS", "Wei JC", "Chiu LT", "Hsu CC", "Hwu CM"], "date": "2022-08-22T00:00:00Z", "doi": "10.3389/fphar.2022.919881", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "919881", "score": 50254.4, "text_hl": "Cardiovascular outcomes of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use in @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@ and @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@chronic obstructive pulmonary disease@@@", "citations": {"NLM": "Yen FS, Wei JC, Chiu LT, Hsu CC, Hwu CM. Cardiovascular outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease Front Pharmacol. 2022;13():919881. PMID: 36071848", "BibTeX": "@article{36071848, title={Cardiovascular outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease}, author={Yen FS and Wei JC and Chiu LT and Hsu CC and Hwu CM}, journal={Front Pharmacol}, volume={13}, pages={919881}}"}}, {"_id": "34033525", "pmid": 34033525, "title": "Metformin: Experimental and Clinical Evidence for a Potential Role in Emphysema Treatment.", "journal": "Am J Respir Crit Care Med", "authors": ["Polverino F", "Wu TD", "Rojas-Quintero J", "Wang X", "Mayo J", "Tomchaney M", "Tram J", "Packard S", "Zhang D", "Cleveland KH", "Cordoba-Lanus E", "Owen CA", "Fawzy A", "Kinney GL", "Hersh CP", "Hansel NN", "Doubleday K", "Sauler M", "Tesfaigzi Y", "Ledford JG", "Casanova C", "Zmijewski J", "Konhilas J", "Langlais PR", "Schnellmann R", "Rahman I", "McCormack M", "Celli B"], "date": "2021-09-15T00:00:00Z", "doi": "10.1164/rccm.202012-4510OC", "meta_date_publication": "2021 Sep 15", "meta_volume": "204", "meta_issue": "6", "meta_pages": "651-666", "score": 50253.934, "text_hl": "Objectives: We sought to investigate whether @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ may ameliorate CS-induced pathologies of @DISEASE_Emphysematous_Cholecystitis @DISEASE_MESH:D041882 @@@emphysematous@@@ @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@chronic obstructive pulmonary disease@@@ (@<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@COPD@@@). ", "citations": {"NLM": "Polverino F, Wu TD, Rojas-Quintero J, Wang X, Mayo J, Tomchaney M, Tram J, Packard S, Zhang D, Cleveland KH, Cordoba-Lanus E, Owen CA, Fawzy A, Kinney GL, Hersh CP, Hansel NN, Doubleday K, Sauler M, Tesfaigzi Y, Ledford JG, Casanova C, Zmijewski J, Konhilas J, Langlais PR, Schnellmann R, Rahman I, McCormack M, Celli B. Metformin: Experimental and Clinical Evidence for a Potential Role in Emphysema Treatment. Am J Respir Crit Care Med. 2021 Sep 15;204(6):651-666. PMID: 34033525", "BibTeX": "@article{34033525, title={Metformin: Experimental and Clinical Evidence for a Potential Role in Emphysema Treatment.}, author={Polverino F and Wu TD and Rojas-Quintero J and Wang X and Mayo J and Tomchaney M and Tram J and Packard S and Zhang D and Cleveland KH and Cordoba-Lanus E and Owen CA and Fawzy A and Kinney GL and Hersh CP and Hansel NN and Doubleday K and Sauler M and Tesfaigzi Y and Ledford JG and Casanova C and Zmijewski J and Konhilas J and Langlais PR and Schnellmann R and Rahman I and McCormack M and Celli B}, journal={Am J Respir Crit Care Med}, volume={204}, number={6}, pages={651-666}}"}}, {"_id": "32581289", "pmid": 32581289, "pmcid": "PMC7314747", "title": "Respiratory outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease", "journal": "Sci Rep", "authors": ["Yen FS", "Wei JC", "Yang YC", "Hsu CC", "Hwu CM"], "date": "2020-06-24T00:00:00Z", "doi": "10.1038/s41598-020-67338-2", "meta_date_publication": "2020 Jun 24", "meta_volume": "10", "meta_issue": "1", "meta_pages": "10298", "score": 50253.88, "text_hl": "Respiratory outcomes of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use in @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@ and @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@chronic obstructive pulmonary disease@@@", "citations": {"NLM": "Yen FS, Wei JC, Yang YC, Hsu CC, Hwu CM. Respiratory outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease Sci Rep. 2020 Jun 24;10(1):10298. PMID: 32581289", "BibTeX": "@article{32581289, title={Respiratory outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease}, author={Yen FS and Wei JC and Yang YC and Hsu CC and Hwu CM}, journal={Sci Rep}, volume={10}, number={1}, pages={10298}}"}}, {"_id": "35512853", "pmid": 35512853, "title": "Metformin suppresses epithelial sodium channel hyperactivation and its associated phenotypes in a mouse model of obstructive lung diseases.", "journal": "J Pharmacol Sci", "authors": ["Nakashima R", "Nohara H", "Takahashi N", "Nasu A", "Hayashi M", "Kishimoto T", "Kamei S", "Fujikawa H", "Maruta K", "Kawakami T", "Eto Y", "Ueno-Shuto K", "Suico MA", "Kai H", "Shuto T"], "date": "2022-06-01T00:00:00Z", "doi": "10.1016/j.jphs.2022.03.002", "meta_date_publication": "2022 Jun", "meta_volume": "149", "meta_issue": "2", "meta_pages": "37-45", "score": 50250.312, "text_hl": "Overall, the present study demonstrates that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ directly inhibits @GENE_SCNN1A @GENE_20276 @@@ENaC@@@ activity in vitro and provides the first evidence of therapeutical benefit of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ for @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@COPD@@@ with higher @GENE_SCNN1A @GENE_20276 @@@ENaC@@@ activity.", "citations": {"NLM": "Nakashima R, Nohara H, Takahashi N, Nasu A, Hayashi M, Kishimoto T, Kamei S, Fujikawa H, Maruta K, Kawakami T, Eto Y, Ueno-Shuto K, Suico MA, Kai H, Shuto T. Metformin suppresses epithelial sodium channel hyperactivation and its associated phenotypes in a mouse model of obstructive lung diseases. J Pharmacol Sci. 2022 Jun;149(2):37-45. PMID: 35512853", "BibTeX": "@article{35512853, title={Metformin suppresses epithelial sodium channel hyperactivation and its associated phenotypes in a mouse model of obstructive lung diseases.}, author={Nakashima R and Nohara H and Takahashi N and Nasu A and Hayashi M and Kishimoto T and Kamei S and Fujikawa H and Maruta K and Kawakami T and Eto Y and Ueno-Shuto K and Suico MA and Kai H and Shuto T}, journal={J Pharmacol Sci}, volume={149}, number={2}, pages={37-45}}"}}, {"_id": "33208304", "pmid": 33208304, "pmcid": "PMC7677354", "title": "FN3K expression in COPD: a potential comorbidity factor for cardiovascular disease", "journal": "BMJ Open Respir Res", "authors": ["Alderawi A", "Caramori G", "Baker EH", "Hitchings AW", "Rahman I", "Rossios C", "Adcock I", "Cassolari P", "Papi A", "Ortega VE", "Curtis JL", "Dunmore S", "Kirkham P"], "date": "2020-11-01T00:00:00Z", "doi": "10.1136/bmjresp-2020-000714", "meta_date_publication": "2020 Nov", "meta_volume": "7", "meta_issue": "1", "meta_pages": "", "score": 50249.184, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ induces increased expression of @GENE_FN3K @GENE_64122 @@@FN3K@@@ in @<m>DISEASE_Pulmonary_Disease_Chronic_Obstructive</m> @DISEASE_MESH:D029424 @@@AECOPD@@@", "citations": {"NLM": "Alderawi A, Caramori G, Baker EH, Hitchings AW, Rahman I, Rossios C, Adcock I, Cassolari P, Papi A, Ortega VE, Curtis JL, Dunmore S, Kirkham P. FN3K expression in COPD: a potential comorbidity factor for cardiovascular disease BMJ Open Respir Res. 2020 Nov;7(1):. PMID: 33208304", "BibTeX": "@article{33208304, title={FN3K expression in COPD: a potential comorbidity factor for cardiovascular disease}, author={Alderawi A and Caramori G and Baker EH and Hitchings AW and Rahman I and Rossios C and Adcock I and Cassolari P and Papi A and Ortega VE and Curtis JL and Dunmore S and Kirkham P}, journal={BMJ Open Respir Res}, volume={7}, number={1}}"}}]}